H. Lovec et al., CYCLIN D1 BCL-1 COOPERATES WITH MYC GENES IN THE GENERATION OF B-CELLLYMPHOMA IN TRANSGENIC MICE, EMBO journal, 13(15), 1994, pp. 3487-3495
The chromosomal translocation t(11:14) is associated with human lympho
id neoplasia affecting centrocytic B-cells of intermediate differentia
tion; As a consequence the cyclin D1 (bcl-1) gene is juxtaposed to the
immunoglobulin heavy chain enhancer E mu. To show that transcriptiona
l activation of cyclin D1 is causally involved in the generation of B-
cell neoplasia we have generated transgenic mice that Carry a cyclin D
1 gene under the transcriptional control of the E mu element. E mu cyc
lin D1 transgenic mice show only very subtle alterations in the cyclin
g behaviour of B cell populations in the bone marrow compared with nor
mal mice add do not develop lymphoid tumours. However, E mu-directed c
oexpression of cyclin D1 and N-MYC or L-MYC in double transgenic mice
reveals a strong cooperative effect between MYC and cyclin D1 provokin
g the rapid development of clonal pre-B and B-cell lymphomas. Interest
ingly, crossing of cyclin D1 transgenic mice with E mu L-myc transgeni
cs that express their transgene in both B- and T-cells but predominant
ly develop T-cell tumours leads in double transgenics exclusively to B
-cell neoplasia. The data presented here demonstrate that transcriptio
nal activation of cyclin D1 can oncogenically transform B-cells in con
cert with a myc gene. They establish cyclin D1 as a protooncogene whos
e activity appears to depend on a specific cell type as well as on a s
pecific cooperating partner and link disturbances in the regulation of
cell cycle progression to the development of human malignancies.